-
Signature
-
/s/ John S. Hess, Jr. under Power of Attorney
-
Stock symbol
-
UTHR
-
Transactions as of
-
Dec 1, 2025
-
Transactions value $
-
-$7,013,066
-
Form type
-
4
-
Date filed
-
12/2/2025, 04:32 PM
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| EDGEMOND JAMES |
CFO AND TREASURER |
C/O UNITED THERAPEUTICS CORPORATION, 1000 SPRING STREET, SILVER SPRING |
/s/ John S. Hess, Jr. under Power of Attorney |
2025-12-02 |
0001636178 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
UTHR |
Common Stock |
Options Exercise |
$3.07M |
+21K |
+257.92% |
$146.03 |
29.1K |
Dec 1, 2025 |
Direct |
F1 |
| transaction |
UTHR |
Common Stock |
Sale |
-$1.36M |
-2.85K |
-9.79% |
$477.98 |
26.3K |
Dec 1, 2025 |
Direct |
F1, F2 |
| transaction |
UTHR |
Common Stock |
Sale |
-$2.01M |
-4.2K |
-15.97% |
$479.11 |
22.1K |
Dec 1, 2025 |
Direct |
F1, F3 |
| transaction |
UTHR |
Common Stock |
Sale |
-$3.62M |
-7.55K |
-34.19% |
$479.92 |
14.5K |
Dec 1, 2025 |
Direct |
F1, F4 |
| transaction |
UTHR |
Common Stock |
Sale |
-$1.86M |
-3.86K |
-26.54% |
$480.95 |
10.7K |
Dec 1, 2025 |
Direct |
F1, F5 |
| transaction |
UTHR |
Common Stock |
Sale |
-$711K |
-1.48K |
-13.82% |
$481.80 |
9.21K |
Dec 1, 2025 |
Direct |
F1, F6 |
| transaction |
UTHR |
Common Stock |
Sale |
-$436K |
-903 |
-9.81% |
$483.04 |
8.3K |
Dec 1, 2025 |
Direct |
F1, F7 |
| transaction |
UTHR |
Common Stock |
Sale |
-$77.5K |
-160 |
-1.93% |
$484.68 |
8.14K |
Dec 1, 2025 |
Direct |
F1 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
UTHR |
Stock Option |
Options Exercise |
$0 |
-517 |
-100% |
$0.00 |
0 |
Dec 1, 2025 |
Common Stock |
517 |
$146.03 |
Direct |
F1 |
| transaction |
UTHR |
Stock Option |
Options Exercise |
$0 |
-20.5K |
-45.52% |
$0.00 |
24.5K |
Dec 1, 2025 |
Common Stock |
20.5K |
$146.03 |
Direct |
F1 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: